e-learning
resources
Barcelona 2010
Wednesday, 22.09.2010
New mechanisms in chronic lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Dysregulated ECM stability: A pathomechanism in chronic obstructive pulmonary disease?
N. Kneidinger, A. Nave, G. Kwapiszewska, C. Vogelmeier, W. Seeger, R. Morty (Giessen, Marburg, Germany)
Source:
Annual Congress 2010 - New mechanisms in chronic lung diseases
Session:
New mechanisms in chronic lung diseases
Session type:
Oral Presentation
Number:
5541
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Kneidinger, A. Nave, G. Kwapiszewska, C. Vogelmeier, W. Seeger, R. Morty (Giessen, Marburg, Germany). Dysregulated ECM stability: A pathomechanism in chronic obstructive pulmonary disease?. Eur Respir J 2010; 36: Suppl. 54, 5541
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Systemic inflammation: a link between chronic obstructive pulmonary disease and lung cancer?
Source: Annual Congress 2009 - Biological and clinical markers in lung cancer
Year: 2009
Age-dependent systemic elastin degradation is enhanced in chronic obstructive pulmonary disease
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016
Erythropoietin dysregulation in chronic obstructive pulmonary disease
Source: Annual Congress 2008 - COPD
Year: 2008
Mediators of lymphoid neogenesis in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2010 - Immune modulation of airways diseases
Year: 2010
Dysregulation of serum miRNA in chronic obstructive pulmonary disease
Source: International Congress 2015 – Genetics, genomics and exposures in asthma and COPD
Year: 2015
Regulation disorders of pulmonary lipid metabolism in chronic obstructive pulmonary disease
Source: International Congress 2019 – Research and innovation in airway diseases
Year: 2019
The role of inflamatory markers in obstructive pulmonary disease
Source: Annual Congress 2012 - Distinguishing phenotypes and dealing with comorbidities in primary care
Year: 2012
Epigenetic-like regulation of signalling proteins in chronic obstructive pulmonary disease
Source: International Congress 2019 – Effects of environmental exposures in lung pathology and the underlying mechanisms
Year: 2019
Inflammatory cell microlocalisation and airway dysfunction: cause and effect?
Source: Eur Respir J 2007; 30: 1043-1056
Year: 2007
Can ADMA play a role in determining pulmonary hypertension related to chronic obstructive lung disease?
Source: International Congress 2016 – Pulmonary hypertension in lung disease
Year: 2016
Emphysema contribution to the progression of chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 654s
Year: 2006
Systemic vascular function in chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment
Year: 2013
IL-36? – a key mediator of neutrophilic inflammation in chronic obstructive pulmonary disease
Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease
Year: 2021
What is new in chronic obstructive pulmonary disease?
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 978-1-904097-51-8, page=153
Year: 2007
The link between inflammation and lung cancer: lessons from chronic obstructive pulmonary disease
Source: International Congress 2018 – Scientific Year in Review
Year: 2018
Chronic obstructive pulmonary disease - cardiovascular sequel of bronchodilation?
Source: International Congress 2018 – PG19 Heart-lung interaction
Year: 2018
Cytokine-induced mechanisms of osteopenic syndrome in the chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2001; 18: Suppl. 33, 214s
Year: 2001
Inflammation and depression in chronic obstructive pulmonary disease
Source: Eur Respir J 2007; 30: Suppl. 51, 718s
Year: 2007
Characterization of elastin degradation biomarkers in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous
Year: 2008
Interleukin-18 production and pulmonary function in COPD
Source: Eur Respir J 2008; 31: 287-297
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept